Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus.

Compare the cost and effectiveness of nonbenzodiazepine antiepileptic drugs (non-BZD AEDs) for treatment of BZD-resistant convulsive status epilepticus (SE).